Tower Research Capital LLC (TRC) - TREACE MED CONCEPTS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TREACE MED CONCEPTS INC
ValueSharesWeighting
Q3 2023$53,501
+17.2%
4,081
+128.6%
0.00%0.0%
Q2 2023$45,660
+175515.4%
1,785
+72.8%
0.00%
+100.0%
Q1 2023$26
-72.3%
1,033
-74.5%
0.00%
-75.0%
Q4 2022$94
-99.9%
4,053
-24.4%
0.00%
+100.0%
Q3 2022$118,000
+107.0%
5,363
+35.2%
0.00%
+100.0%
Q2 2022$57,000
+111.1%
3,966
+181.7%
0.00%
Q1 2022$27,000
+92.9%
1,408
+88.7%
0.00%
Q4 2021$14,000
+55.6%
746
+124.0%
0.00%
Q3 2021$9,000
+200.0%
333
+278.4%
0.00%
Q2 2021$3,000880.00%
Other shareholders
TREACE MED CONCEPTS INC shareholders Q4 2023
NameSharesValueWeighting ↓
NEXT CENTURY GROWTH INVESTORS LLC 1,581,634$40,458,1973.90%
Millrace Asset Group, Inc. 72,207$1,8471.94%
Perceptive Advisors 2,217,250$56,717,2551.64%
SECTORAL ASSET MANAGEMENT INC 379,443$9,706,1521.62%
EMERALD MUTUAL FUND ADVISERS TRUST 1,120,875$28,671,9831.56%
EMERALD ADVISERS, LLC 1,366,138$34,945,8101.53%
FORMULA GROWTH LTD 117,750$3,012,0450.96%
OBERWEIS ASSET MANAGEMENT INC/ 251,500$6,433,3700.78%
Novo Holdings A/S 360,000$9,208,8000.71%
Intrinsic Edge Capital Management LLC 354,585$9,070,2840.65%
View complete list of TREACE MED CONCEPTS INC shareholders